CCL11 has been implicated in various diseases, including fibromyalgia (72), osteoporosis (73), metabolic conditions like non-alcoholic fatty liver disease (NAFLD) (74), accelerated aging, and neurodegenerative disorders such as chronic traumatic encephalopathy (75), multiple sclerosis (76), and the chemotherapy and long COVID-related brain fog (77). This evidence concerns the gene CCL11 and multiple sclerosis.